An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis

Oral Cyclophosphamide Is on the Verge of Extinction as Therapy for Severe Autoimmune Diseases (Especially Lupus): Should Nephrologists Care?

(2010) Lee A. Hebert et al.   NEPHRON CLINICAL PRACTICE

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus

(2009) Y.L. Wu et al.   CYTOGENETIC AND GENOME RESEARCH

Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

(2009) H. A. Austin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Random Spot Urine Protein/Creatinine Ratio Is Unreliable for Estimating 24-Hour Proteinuria in Individual Systemic Lupus Erythematosus Nephritis Patients

(2009) Lee A. Hebert et al.   NEPHRON CLINICAL PRACTICE

D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus

(2008) H. Wu et al.   Clinical Journal of the American Society of Nephrology

Relationship between Albuminuria and Total Proteinuria in Systemic Lupus Erythematosus Nephritis: Diagnostic and Therapeutic Implications

(2008) D. J. Birmingham et al.   Clinical Journal of the American Society of Nephrology